HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 232 filers reported holding HORIZON PHARMA PLC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,949,000 | +124.2% | 225,074 | +65.7% | 0.05% | +122.7% |
| Q4 2018 | $2,654,000 | +452.9% | 135,830 | +453.7% | 0.02% | +633.3% |
| Q3 2018 | $480,000 | -32.3% | 24,530 | -42.7% | 0.00% | -25.0% |
| Q2 2018 | $709,000 | -85.7% | 42,836 | -86.0% | 0.00% | -85.7% |
| Q4 2016 | $4,958,000 | +181.5% | 306,443 | +215.5% | 0.03% | +211.1% |
| Q3 2016 | $1,761,000 | +85.6% | 97,143 | +68.7% | 0.01% | +125.0% |
| Q2 2016 | $949,000 | +273.6% | 57,600 | +276.5% | 0.00% | +300.0% |
| Q1 2016 | $254,000 | -67.2% | 15,300 | -57.2% | 0.00% | -75.0% |
| Q4 2015 | $774,000 | -31.1% | 35,709 | -37.0% | 0.00% | -33.3% |
| Q3 2015 | $1,124,000 | -92.5% | 56,700 | -86.9% | 0.01% | -92.2% |
| Q2 2015 | $15,050,000 | +128.5% | 433,233 | -15.2% | 0.08% | +97.4% |
| Q4 2014 | $6,587,000 | +1798.3% | 511,000 | +1709.7% | 0.04% | +1850.0% |
| Q3 2014 | $347,000 | – | 28,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
| Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
| Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
| JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
| Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
| Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
| Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
| KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
| 1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |